Robert Wasserman

Stock Analyst at Benchmark

(0)
# 3127
Out of 5,270 analysts
118
Total ratings
42.65%
Success rate
3.36%
Average return
23 Stocks
Name Action Price Target Current % Upside Ratings Updated
AbCellera Biologics
Reiterates: Hold
n/a
n/a n/a 6 Mar 3, 2025
Integer Holdings
Maintains: Strong Buy
140 150
120.07 24.93% 10 Feb 21, 2025
Halozyme Therapeutic...
Reiterates: Buy
75 75
57.92 29.49% 8 Feb 20, 2025
Ligand Pharmaceutica...
Reiterates: Buy
135 135
112.42 20.09% 10 Dec 23, 2024
BioLife Solns
Reiterates: Buy
30 30
24.42 22.85% 6 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
8 8
1.13 607.96% 6 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
3.42 133.92% 7 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
5 5
1.4 257.14% 3 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
8 12
6.83 75.7% 17 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 7 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Speculative Buy
5 3
0.32 837.5% 5 Aug 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
95 95
61.24 55.13% 5 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
n/a
n/a n/a 3 Aug 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
12 12
2.3 421.74% 6 Jul 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
45 45
38.28 17.55% 6 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
4
3.53 13.31% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
4
0.5 700% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
7
n/a n/a 1 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Speculative Buy
75
1.52 4834.21% 2 Apr 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Oct 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Speculative Buy
7
n/a n/a 3 Aug 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
580
521.59 11.2% 1 Jul 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
1386
n/a n/a 1 Aug 28, 2018